These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Efficacy and safety of bosentan for pulmonary arterial hypertension in adults with congenital heart disease. Monfredi O, Griffiths L, Clarke B, Mahadevan VS. Am J Cardiol; 2011 Nov 15; 108(10):1483-8. PubMed ID: 21943933 [Abstract] [Full Text] [Related]
7. Bosentan for the treatment of pulmonary arterial hypertension associated with congenital heart defects. Sitbon O, Beghetti M, Petit J, Iserin L, Humbert M, Gressin V, Simonneau G. Eur J Clin Invest; 2006 Sep 15; 36 Suppl 3():25-31. PubMed ID: 16919007 [Abstract] [Full Text] [Related]
8. Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study. Galiè N, Beghetti M, Gatzoulis MA, Granton J, Berger RM, Lauer A, Chiossi E, Landzberg M, Bosentan Randomized Trial of Endothelin Antagonist Therapy-5 (BREATHE-5) Investigators. Circulation; 2006 Jul 04; 114(1):48-54. PubMed ID: 16801459 [Abstract] [Full Text] [Related]
9. Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease. Apostolopoulou SC, Manginas A, Cokkinos DV, Rammos S. Heart; 2005 Nov 04; 91(11):1447-52. PubMed ID: 15761050 [Abstract] [Full Text] [Related]
16. Bosentan therapy for pulmonary arterial hypertension. Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, Pulido T, Frost A, Roux S, Leconte I, Landzberg M, Simonneau G. N Engl J Med; 2002 Mar 21; 346(12):896-903. PubMed ID: 11907289 [Abstract] [Full Text] [Related]
18. Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension. Sitbon O, Gressin V, Speich R, Macdonald PS, Opravil M, Cooper DA, Fourme T, Humbert M, Delfraissy JF, Simonneau G. Am J Respir Crit Care Med; 2004 Dec 01; 170(11):1212-7. PubMed ID: 15317666 [Abstract] [Full Text] [Related]
19. Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist? van Loon RL, Hoendermis ES, Duffels MG, Vonk-Noordegraaf A, Mulder BJ, Hillege HL, Berger RM. Am Heart J; 2007 Oct 01; 154(4):776-82. PubMed ID: 17893008 [Abstract] [Full Text] [Related]